InterStim Patients Must Keep Voiding Diary - CMS Coverage Decision
This article was originally published in The Gray Sheet
Executive Summary
Patients with urinary incontinence treated with sacral nerve stimulation (SNS) must keep a voiding diary to assess the therapy's effectiveness, according to a national Medicare coverage determination issued by CMS (formerly HCFA) on June 29.
You may also be interested in...
Medicare Reform Should Not Undercut Local Coverage Process – Medtronic
HHS should ensure that Medicare reform efforts to consolidate claims processing do not erode the autonomy of carrier medical directors to make local coverage decisions, Medtronic maintains in March 5 comments to the HHS Secretary's Advisory Committee on Regulatory Reform
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.